Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19

Summary

EC CORONACOLCHI is a multicenter, double-blind and randomized clinical trial with two branches. Patients who meet all the inclusion criteria and none of the exclusion criteria will be randomized 1: 1 to be included in one of the following groups: * Experimental group: colchicine for 2 weeks orally at the doses described, added to the standard treatment of COVID-19. * Control group: placebo for 2 weeks orally added to standard COVID-19 treatment.

Timeline

Start

2020-09-08

Primary completion

2021-09-01

Completion

2022-01-01

Drugs

Indications